Cargando…

Towards Multi-Organoid Systems for Drug Screening Applications

A low percentage of novel drug candidates succeed and reach the end of the drug discovery pipeline, mainly due to poor initial screening and assessment of the effects of the drug and its metabolites over various tissues in the human body. For that, emerging technologies involving the production of o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miranda, Cláudia C., Fernandes, Tiago G., Diogo, Maria Margarida, Cabral, Joaquim M. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163436/ https://www.ncbi.nlm.nih.gov/pubmed/29933623 http://dx.doi.org/10.3390/bioengineering5030049

Ejemplares similares

Human multilineage pro-epicardium/foregut organoids support the development of an epicardium/myocardium organoid
por: Branco, Mariana A., et al.
Publicado: (2022)

Multifactorial Modeling Reveals a Dominant Role of Wnt Signaling in Lineage Commitment of Human Pluripotent Stem Cells
por: Dias, Tiago P., et al.
Publicado: (2019)

Developmental Toxicity Studies: The Path towards Humanized 3D Stem Cell-Based Models
por: Branco, Mariana A., et al.
Publicado: (2023)

Modeling Rett Syndrome with Human Pluripotent Stem Cells: Mechanistic Outcomes and Future Clinical Perspectives
por: Gomes, Ana Rita, et al.
Publicado: (2021)

Modeling Rett Syndrome With Human Patient-Specific Forebrain Organoids
por: Gomes, Ana Rita, et al.
Publicado: (2020)

Design Principles for Pluripotent Stem Cell-Derived Organoid Engineering
por: Silva, Teresa P., et al.
Publicado: (2019)

New Insights into the Mechanisms of Embryonic Stem Cell Self-Renewal under Hypoxia: A Multifactorial Analysis Approach
por: Barbosa, Hélder S. C., et al.
Publicado: (2012)

Organoids as complex (bio)systems
por: Fernandes, Tiago G.
Publicado: (2023)

Defined Essential 8™ Medium and Vitronectin Efficiently Support Scalable Xeno-Free Expansion of Human Induced Pluripotent Stem Cells in Stirred Microcarrier Culture Systems
por: Badenes, Sara M., et al.
Publicado: (2016)

Correction: Defined Essential 8™ Medium and Vitronectin Efficiently Support Scalable Xeno-Free Expansion of Human Induced Pluripotent Stem Cells in Stirred Microcarrier Culture Systems
por: Badenes, Sara M., et al.
Publicado: (2016)

From Human Pluripotent Stem Cells to 3D Cardiac Microtissues: Progress, Applications and Challenges
por: Branco, Mariana A., et al.
Publicado: (2020)

Xeno-Free Integrated Platform for Robust Production of Cardiomyocyte Sheets from hiPSCs
por: Dias, Tiago P., et al.
Publicado: (2022)

Cost-Effective Mechanical Aggregation of Cardiac Progenitors and Encapsulation in Matrigel Support Self-Organization in a Dynamic Culture Environment
por: Dias, Tiago P., et al.
Publicado: (2022)

Application of Cancer Organoid Model for Drug Screening and Personalized Therapy
por: Kondo, Jumpei, et al.
Publicado: (2019)

Stem Cell Bioprocessing and Manufacturing
por: Cabral, Joaquim M.S., et al.
Publicado: (2020)

Single-Use Bioreactors for Human Pluripotent and Adult Stem Cells: Towards Regenerative Medicine Applications
por: Nogueira, Diogo E.S., et al.
Publicado: (2021)

Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
por: Zhou, Zilong, et al.
Publicado: (2021)

Patient-derived parathyroid organoids as a tracer and drug-screening application model
por: Noltes, Milou E., et al.
Publicado: (2022)

Organoid of ovarian cancer: genomic analysis and drug screening
por: Liu, H.-D., et al.
Publicado: (2020)

Maturation of Human Pluripotent Stem Cell-Derived Cerebellar Neurons in the Absence of Co-culture
por: Silva, Teresa P., et al.
Publicado: (2020)

Engineering Organoids for in vitro Modeling of Phenylketonuria
por: Borges, Alice C., et al.
Publicado: (2022)

Production of Human Pluripotent Stem Cell-Derived Hepatic Cell Lineages and Liver Organoids: Current Status and Potential Applications
por: Cotovio, João P., et al.
Publicado: (2020)

Transcriptomic analysis of 3D Cardiac Differentiation of Human Induced Pluripotent Stem Cells Reveals Faster Cardiomyocyte Maturation Compared to 2D Culture
por: Branco, Mariana A., et al.
Publicado: (2019)

Drug screening model meets cancer organoid technology
por: Liu, Chen, et al.
Publicado: (2020)

Direct transfection of clonal organoids in Matrigel microbeads: a promising approach toward organoid-based genetic screens
por: Laperrousaz, Bastien, et al.
Publicado: (2018)

A Dynamic 3D Aggregate-Based System for the Successful Expansion and Neural Induction of Human Pluripotent Stem Cells
por: Miranda, Cláudia C., et al.
Publicado: (2022)

Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application
por: Ren, Xiaoxue, et al.
Publicado: (2023)

Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening
por: Li, Zhichao, et al.
Publicado: (2020)

Organoid and microfluidics-based platforms for drug screening in COVID-19
por: Ramezankhani, Roya, et al.
Publicado: (2022)

Drug screening at single-organoid resolution via bioprinting and interferometry
por: Tebon, Peyton J., et al.
Publicado: (2023)

Brain organoids are new tool for drug screening of neurological diseases
por: Zhou, Jin-Qi, et al.
Publicado: (2023)

Utility of the Cerebral Organoid Glioma ‘GLICO’ Model for Screening Applications
por: Weth, Freya R., et al.
Publicado: (2022)

Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids
por: Schuster, Brooke, et al.
Publicado: (2020)

Patient‐derived organoids for personalized gallbladder cancer modelling and drug screening
por: Yuan, Bo, et al.
Publicado: (2022)

Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening
por: Xie, Cuiying, et al.
Publicado: (2023)

Towards organoid culture without Matrigel
por: Kozlowski, Mark T., et al.
Publicado: (2021)

Immersion Bioprinting of Tumor Organoids in Multi-Well Plates for Increasing Chemotherapy Screening Throughput
por: Maloney, Erin, et al.
Publicado: (2020)

Drug Metabolism of Hepatocyte-like Organoids and Their Applicability in In Vitro Toxicity Testing
por: Bouwmeester, Manon C., et al.
Publicado: (2023)

Normal and tumor-derived organoids as a drug screening platform for tumor-specific drug vulnerabilities
por: Calandrini, Camilla, et al.
Publicado: (2022)

Hydrogels in the treatment of rheumatoid arthritis: drug delivery systems and artificial matrices for dynamic in vitro models
por: Oliveira, Isabel Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fajkh986gbscshprbr7dpri9tg